NPC1 and infection: Overall, this study identifies FIASMAs as host cell–directed therapeutics for treating infections caused by A. phagocytophilum, C. burnetii, C. pneumoniae, and potentially other pathogens whose infectivity, intracellular growth, and/or survival are strongly influenced by NPC1-trafficked LDL cholesterol.